APR 30, 2020 3:33 PM PDT

Researchers Use AI to Accelerate COVID-19 Drug Development

WRITTEN BY: Annie Lennon

Researchers from the National University of Singapore (NUS) have developed an artificial intelligence platform to accelerate the process of finding drugs for bacterial and viral infections. In particular, they intend to use their system to combat COVID-19. 

The process of developing new drugs in response to the emergence of new bacterial and viral infections usually involves testing a combination of many different, existing drugs. 

Traditional methods make it hard to track how drugs interact due to the millions, if not billions, of possible interactions. Meanwhile, as dosage is decided by trial and error, the process quickly becomes very time-consuming. Then, as these approaches are usually carried out in vitro, there is no guarantee that positive results at the petri dish-level will translate into the human body. Collectively, these factors make drug development time-consuming, costly and extremely laborious. 

To accelerate the process and yield more reliable results, Professor Dean Ho from NUS and his colleagues from Shanghai Jiao Tong University developed an artificial intelligence platform called Identif.AI. It works by using historical data on drug interactions to predict how selected drug candidates will interact, as well as which further tests will be needed. 

To test their platform, the researchers carefully selected 12 drug candidates to treat a lung infection caused by the vesicular stomatitis virus (VSV), and then ran them through the system. Ho says, “Using IDentif.AI, we took three days to identify multiple optimal drug regimens out of billions of possible combinations that reduced the VSV infection to 1.5% with no apparent adverse impact. This speed and accuracy in discovering new drug combination therapies is completely unprecedented.”

Having proven its efficacy, the team now hopes to use the platform to tackle COVID-19. Beyond being able to quickly identify drug candidates and streamline experiments needed to test them, the researchers hope that their system will be able to identify whether different treatments suit different individuals.

“As the development of vaccines and antibody therapies for COVID-19 are ongoing, we will need a rapid therapeutic strategy that addresses the virus which may evolve over time...Our strength is that we can perform one experiment and come out with a list of drug combinations for treatment within days. And in time, if patients do not respond well to the first combinations of drugs, we can derive new combinations within days to re-optimize their care.” says Ho. 


Sources: Futurity, Advanced Therapeutics, Technology Networks 

About the Author
  • Science writer with a keen interest in behavioral biology, consciousness medicine and technology. Her current focus is how the interplay of these fields can create meaningful interactions, products and environments.
You May Also Like
MAY 11, 2021
Cardiology
Red Blood Cells Could Help Predict Recovery in Cardiovascular Patients
MAY 11, 2021
Red Blood Cells Could Help Predict Recovery in Cardiovascular Patients
Cells are one of the basic building blocks of life. There are hundreds of different cell types, and they all work togeth ...
MAY 28, 2021
Cell & Molecular Biology
Some Animals Can Breathe Through Their Whats?
MAY 28, 2021
Some Animals Can Breathe Through Their Whats?
There are some aquatic animals like sea cucumbers and some types of catfish that can survive in environments with limite ...
JUN 01, 2021
Immunology
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
JUN 01, 2021
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
Seasonal flu vaccines only work around 40 to 60 percent of the time, says the U.S. Centers for Disease Control and Preve ...
JUN 28, 2021
Microbiology
Small Clinical Trial Suggests New Edible Cholera Vaccine Is Safe
JUN 28, 2021
Small Clinical Trial Suggests New Edible Cholera Vaccine Is Safe
According to WHO there have been six cholera pandemics since the pathogen emerged from the Ganges river delta sometime i ...
JUL 05, 2021
Neuroscience
People with Autism More Likely to Self-Medicate with Recreational Drugs
JUL 05, 2021
People with Autism More Likely to Self-Medicate with Recreational Drugs
Researchers from the University of Cambridge have found that people with autism are more likely than people without the ...
JUL 23, 2021
Cancer
Repurposed Antibiotics Show Promise Against Skin Cancer
JUL 23, 2021
Repurposed Antibiotics Show Promise Against Skin Cancer
In experiments with mice, researchers from the Netherlands have found that some antibiotics may be effective in tre ...
Loading Comments...